Analysts on Wall Street project that Agilysys (AGYS) will announce quarterly earnings of $0.26 per share in its forthcoming report, representing a decline of 18.8% year over year. Revenues are projected to reach $71.28 million, increasing 14.6% from the same quarter last year. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights. Given this perspective, it's time to examine the average forecasts of specific Agilysys metrics that are routinely monitored and predicted by Wall Street analysts. The consensus estimate for 'Net revenue- Products' stands at $10.03 million. The estimate indicates a change of -8.7% from the prior-year quarter. Based on the collective assessment of analysts, 'Net revenue- Subscription and maintenance' should arrive at $45.39 million. The estimate indicates a change of +24.1% from the prior-year quarter. The combined assessment of analysts suggests that 'Net revenue- Professional services' will likely reach $15.85 million. The estimate indicates a change of +8.2% from the prior-year quarter. View all Key Company Metrics for Agilysys here>>> Shares of Agilysys have demonstrated returns of +23.7% over the past month compared to the Zacks S&P 500 composite's +9.9% change. With a Zacks Rank #4 (Sell), AGYS is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agilysys, Inc. (AGYS):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Agilysys (AGYS) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...